The largest database of trusted experimental protocols

A549 cells

Manufactured by Lonza
Sourced in United States

A549 cells are a type of human alveolar basal epithelial cell line derived from lung carcinoma tissue. They are commonly used in cell biology research as a model for studying various cellular processes and evaluating the effects of drugs or other compounds on lung cells.

Automatically generated - may contain errors

2 protocols using a549 cells

1

Cytokine Response to H. pylori VacA in Lung Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549 cells (American Type Culture Collection, Rockville, MD, USA) and NHBE cells (CC-2541, Lonza, Walkersville, VA, USA) were maintained in, respectively, Dulbecco’s modified minimal essential medium (DMEM; Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine serum (FBS; Invitrogen) and bronchial epithelial growth medium (BEGM; Lonza) in a humidified incubator (5% CO2 at 37°C).
The toxin-producing H. pylori strain, ATCC 49503, was the source of VacA, which was purified as described previously [12 (link)].
To quantify cytokine production, A549 cells were seeded in 6-well plates at a density of 3.0 × 105 per well and NHBE cells in 12-well plates at a density of 1.0 × 105 per well. At subconfluence, serum-free medium was added to the wells. Cells were subsequently stimulated for 3, 6, 12, and 24 h with 1, 10, 30, 60, or 120 nM VacA or heat-inactivated VacA (100°C, 10 min; iVacA control). These VacA concentrations have been used for the purpose of investigating the effects of toxin on gastric epithelial cells [13 (link)]. Changes in cell morphology were assessed by phase-contrast light microscopy.
+ Open protocol
+ Expand
2

LCMV Cl13 infection in A549 cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549 cells (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM) (Lonza, Walkersville, MD, USA) supplemented with 2 mM l-glutamine, 50 U ml−1 penicillin, and 50 mg ml−1 streptomycin (Gibco, Grand Island, NY, USA), plus 10% heat-inactivated fetal bovine serum (Lonza). The cells were maintained in 175-cm2 flasks at a density of 0.5 × 106 to 1 × 106 cells ml−1 in a total volume of 30 ml. A total of 1 × 106 A549 cells were left untreated or pretreated for 1 h with 20 or 100 ng ml−1 human recombinant IL-27 (Biolegend). The cells were subsequently infected with LCMV Cl13 at a multiplicity of infection (MOI) of 0.05 or 0.5. After 1 day, the cells were washed with PBS and collected in lysis buffer (Qiagen) for RNA analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!